Advertisement
Advertisement
U.S. markets close in 2 hours 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

UBS (Lux) Equity SICAV - European High Dividend (EUR) U-X-acc (0P0000RXFO.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
14,848.20-46.60 (-0.31%)
As of 09:00PM CET. Market open.
Advertisement
Full screen
Loading interactive chart...
  • PR Newswire

    BERGENBIO ANNOUNCES LAUNCH OF BUSINESS STRATEGY FOCUSED ON NSCLC AND COVID-19

    BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announces today an update on its business strategy. BerGenBio will now focus on two key indications; 1st line non-small cell lung cancer (NSCLC) and COVID-19, which the Company believes offer the optimal path towards translating BerGenBio's strong scientific foundation into significant value generation from marketed products to address unmet medical nee

Advertisement
Advertisement